Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masahiko Mihara
Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis
Open Access Rheumatology: Research and Reviews
Rheumatology
Anti-Il-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection Than Anti-TNF- Antibody in Mice
Clinical and Developmental Immunology
Related publications
Rosuvastatin for Tocilizumab, an Interleukin-6 Receptor Antibody-Induced Dyslipidemia in a Diabetic Patient Complicated With Rheumatoid Arthritis
Journal of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Anti-Interleukin 6 Receptor Antibody Treatment in Rheumatic Disease
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Exacerbation of Chronic Active Epstein-Barr Virus Infection in a Patient With Rheumatoid Arthritis Receiving Humanised Anti-Interleukin-6 Receptor Monoclonal Antibody
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Immunotherapy of Tocilizumab for Rheumatoid Arthritis
Journal of Clinical & Cellular Immunology
Efficacy of Epidural Administration of Anti-Interleukin-6 Receptor Antibody Onto Spinal Nerve for Treatment of Sciatica
Global Spine Journal
Orthopedics
Surgery
Neurology
Sports Medicine
A Humanized Antibody That Binds to the Interleukin 2 Receptor.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Anti-Interleukin-6 Receptor Antibody Therapy —From Bedside to Bench—
Japanese Journal of Clinical Immunology
Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis
Medical Council
Sarilumab: A New IL-6 Receptor Blocker for Rheumatoid Arthritis
Prescriber
Pharmacology
